In the last trading session, 1.6 million Sana Biotechnology Inc (NASDAQ:SANA) shares changed hands as the company’s beta touched 1.31. With the company’s per share price at $2.78 changed hands at $0.23 or 9.02% during last session, the market valuation stood at $676.67M. SANA’s last price was a discount, traded about -331.65% off its 52-week high of $12.00. The share price had its 52-week low at $2.29, which suggests the last value was 17.63% up since then. When we look at Sana Biotechnology Inc’s average trading volume, we note the 10-day average is 1.79 million shares, with the 3-month average coming to 1.46 million.
Analysts gave the Sana Biotechnology Inc (SANA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.86. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SANA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Sana Biotechnology Inc’s EPS for the current quarter is expected to be -0.23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA was in green as seen at the end of in last trading. With action 18.30%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -31.86%, with the 5-day performance at 18.30% in the green. However, in the 30-day time frame, Sana Biotechnology Inc (NASDAQ:SANA) is -24.04% down. Looking at the short shares, we see there were 35.37 million shares sold at short interest cover period of 25.47 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 65.25% from its current market value. According to analyst projections, SANA’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -187.77% plunge from its current level, while the stock would need to soar -187.77% for it to hit the projected low.
Sana Biotechnology Inc (SANA) estimates and forecasts
Data shows that the Sana Biotechnology Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -62.93% over the past 6 months, a 24.54% in annual growth rate that is considerably higher than the industry average of 17.70%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -83.13%. The 2024 estimates are for Sana Biotechnology Inc earnings to increase by 17.94%.
SANA Dividends
Sana Biotechnology Inc is expected to release its next quarterly earnings report in January.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.63% of Sana Biotechnology Inc shares while 92.46% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 101.20%. There are 92.46% institutions holding the Sana Biotechnology Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 12.5041% of the shares, roughly 27.17 million SANA shares worth $148.35 million.
FLAGSHIP PIONEERING INC. holds the second largest percentage of outstanding shares, with 11.5062% or 25.0 million shares worth $136.51 million as of 2024-06-30.
